Results 241 to 250 of about 192,839 (256)

Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease

Ophthalmology, 2019
Peter J Kertes, R Geoff Williams, Emmanouil Rampakakis   +2 more
exaly  

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema

Ophthalmology, 2017
John F Payne, Charles C Wykoff, W Lloyd Clark   +2 more
exaly  

Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2015
Charles C Wykoff, Daniel E Croft, David M Brown   +2 more
exaly  

Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen

Ophthalmology, 2019
Mark C Gillies, Alex P Hunyor, Andrew Chang   +2 more
exaly  

Photoinduced resonant tunneling treated by an extended transfer Hamiltonian method

Physical Review B, 1992
, Apell, , Penn
openaire   +2 more sources

Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab

Ophthalmology, 2017
Nizar Saleh Abdelfattah, Mayss Al-Sheikh, Daniel E Croft   +2 more
exaly  

Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age‐related macular degeneration: a comparative 12 Month study

Acta Ophthalmologica, 2017
Katja Hatz, Christian Prünte
exaly  

Extended compaction of the spine treated with the Boehler method.

Lille chirurgical, 2010
, INGELRANS, , GROULT
openaire   +1 more source

Switching from pro re nata to treat‐and‐extend regimen improves visual acuity in patients with neovascular age‐related macular degeneration

Acta Ophthalmologica, 2017
Jørgen Krohn
exaly  

Treat‐and‐extend versus every‐other‐month regimens with aflibercept in age‐related macular degeneration

Acta Ophthalmologica, 2018
Akira Haga, Takahiro Kawaji, Ryuichi Ideta   +2 more
exaly